JC
TGTX icon

JBF Capital’s TG Therapeutics TGTX Stock Holding History

JBF Capital’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-16,676
Closed -$115K – 105
2014
Q1 		$115K Buy
+16,676
New +$98.7K 0.02% 69

Other funds holding TGTX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JBF Capital's TGTX Position: Q2 2014 in Review

JBF Capital sold out of TG Therapeutics (TGTX) in Q2 2014, closing a stake of 16,676 shares — an estimated $115K sold.

JBF Capital first reported a position in TGTX in Q1 2014 and held it in 1 quarter. The position peaked at $115K in Q1 2014. 67 funds tracked by Wall St. Rank hold TGTX as of Q2 2014.

  • JBF Capital reported no remaining TG Therapeutics position as of Q2 2014 after selling out during the quarter.
  • JBF Capital sold 16,676 TG Therapeutics shares in Q2 2014, an estimated $115K.
  • JBF Capital first reported a position in TG Therapeutics in Q1 2014 and held it in 1 quarter.
  • JBF Capital's TG Therapeutics position peaked at $115K in Q1 2014.
  • 67 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2014.

Based on JBF Capital's 13F filing for Q2 2014, filed 13 Aug 2014.